CORRESP

January 27, 2020

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549-3720

Attention:        Chris Edwards

 

  Re:

Alector, Inc.

Registration Statement on Form S-1

(File No. 333-236094)

Acceleration Request

Requested Date:    Wednesday, January 29, 2020

Requested Time:   4:00 P.M. Eastern Time

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Alector, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-l (File No. 333-236094) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above, or as soon thereafter as practicable, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Michael E. Coke at (650) 565-3596 or Melissa S. Rick at (650) 849-3059.

[Signature page follows]


Sincerely,
ALECTOR, INC.
/s/ Arnon Rosenthal
Arnon Rosenthal, Ph.D.
Chief Executive Officer

 

Enclosures   
cc (w/o enclosures):   

Stephanie Yonker, Ph.D., Alector, Inc.

 

Kenneth A. Clark, Wilson Sonsini Goodrich & Rosati, P.C.

   Michael E. Coke, Wilson Sonsini Goodrich & Rosati, P.C.
   Melissa S. Rick, Wilson Sonsini Goodrich & Rosati, P.C.
   Alan F. Denenberg, Davis Polk & Wardwell LLP
   Stephen Salmon, Davis Polk & Wardwell LLP